Literature DB >> 24730532

Granulomas obstruct lymphatics in all layers of the intestine in Crohn's disease.

Herbert J Van Kruiningen1, Aaron W Hayes, Jean-Frederic Colombel.   

Abstract

After an earlier study defining immunolabeled lymphoid follicles, obstructed lymphatics, and granulomas of the diseased ilea of 24 Crohn's disease patients, we chose to trace the lymphatics of these cases and 10 additional by serial sectioning. Particular attention was given to establishing physical continuity between granuloma-obstructed lymphatics and lymphatics with 'lymphocytic thrombi'. Formalin-fixed paraffin-embedded tissue blocks from resected diseased ilea and proximal colons from 34 patients were reviewed. Patients were 13 men and 21 women, aged 14-60 years. Duration of disease ranged from 1 month to 10 years. Immunohistochemistry employed D2-40 antibody to label lymphatics and anti-CD68 to label granulomas. Twenty-nine of the 34 (85%) resection tissues had lymphangectasia, in mucosa, submucosa, and subserosa. In 53% of the specimens, lymphatics of the various layers were obstructed by granulomas that filled the lumina. In 44%, 15/34, there were also distended lymphatics that were totally plugged with lymphocytes. In 10 of the 15, serial sections revealed continuity between the lymphocyte-plugged lymphatics and the endolymphatic granulomatous obstruction downstream. In 5 of the cases, D2-40 immunostaining revealed redundant lymphatic endothelium interwoven with the granuloma cells. Granulomas totally obstruct lymphatics in all layers of the intestine in Crohn's disease. Upstream of these obstructions, lymphatics are distended with lymphocytes. The degree and extent of this potentially irreversible 'lymphangitis nodosa' have undoubtedly confounded treatment regimens and clinical trials. There currently are no imaging methods to demonstrate the lymphangitis, nor treatments to resolve it.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Crohn's disease; Inflammatory bowel disease; endoscopy; lymphangitis; regional enteritis

Mesh:

Year:  2014        PMID: 24730532     DOI: 10.1111/apm.12268

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  14 in total

1.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

2.  Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen.

Authors:  Jeffrey Harding; Anna Ritter; Aditya Rayasam; Zsuzsanna Fabry; Matyas Sandor
Journal:  Am J Pathol       Date:  2015-02       Impact factor: 4.307

3.  Epithelioid Cell Granulomas in Crohn's Disease Are Differentially Associated With Blood Vessels and Lymphatic Vessels: A Sequential Double Immunostaining Study.

Authors:  Makoto Kodama; Daisuke Kobayashi; Keiko Abe; Rikisaburo Sahara; Tetsuo Yamana; Satomi Furukawa; Takashi Yao; Tomoki Tamura; Soh Okano
Journal:  J Histochem Cytochem       Date:  2020-06-26       Impact factor: 2.479

4.  Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.

Authors:  Rafael S Czepielewski; Emma C Erlich; Emily J Onufer; Shannon Young; Brian T Saunders; Yong-Hyun Han; Mary Wohltmann; Peter L Wang; Ki-Wook Kim; Shashi Kumar; Chyi-Song Hsieh; Joshua P Scallan; Ying Yang; Bernd H Zinselmeyer; Michael J Davis; Gwendalyn J Randolph
Journal:  Immunity       Date:  2021-11-16       Impact factor: 31.745

5.  VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.

Authors:  Silvia D'Alessio; Carmen Correale; Carlotta Tacconi; Alessandro Gandelli; Giovanni Pietrogrande; Stefania Vetrano; Marco Genua; Vincenzo Arena; Antonino Spinelli; Laurent Peyrin-Biroulet; Claudio Fiocchi; Silvio Danese
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

6.  Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?

Authors:  Felix Becker; Sergey Potepalov; Romana Shehzahdi; Michael Bernas; Marlys Witte; Fleurette Abreo; James Traylor; Wayne A Orr; Ikuo Tsunoda; Jonathan Steven Alexander
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

7.  ELISA Serology for Antibodies Against Chlamydia trachomatis in Crohn's Disease.

Authors:  Herbert J Van Kruiningen; Zeinab Helal; Ariane Leroyer; Antonio Garmendia; Corrine Gower-Rousseau
Journal:  Gastroenterology Res       Date:  2018-01-03

Review 8.  Comparative pathophysiology and management of protein-losing enteropathy.

Authors:  Melanie D Craven; Robert J Washabau
Journal:  J Vet Intern Med       Date:  2019-02-14       Impact factor: 3.333

Review 9.  Inflammation and Lymphatic Function.

Authors:  Simon Schwager; Michael Detmar
Journal:  Front Immunol       Date:  2019-02-26       Impact factor: 7.561

10.  A zebrafish model of inflammatory lymphangiogenesis.

Authors:  Kazuhide S Okuda; June Pauline Misa; Stefan H Oehlers; Christopher J Hall; Felix Ellett; Sultan Alasmari; Graham J Lieschke; Kathryn E Crosier; Philip S Crosier; Jonathan W Astin
Journal:  Biol Open       Date:  2015-09-14       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.